Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs conventional opioid anesthesia in elderly patients undergoing robot-assisted radical prostatectomy
ChiCTR2600127848Phase 4Not yet recruiting
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in prostate cancer (PCa) (2 arms), sponsored by Dalian Municipal Central Hospital. Primary endpoint: QoR-40 Scale Score. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on ChiCTR2600127848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127848.